Cancer-Causing Proteins Hickory NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Terry Sarantou
(828) 327-9178
415 N Center St
Hickory, NC
Specialty
General Surgery, Surgical Oncology

Data Provided by:
Piyapong Vongkovit, MD
(828) 324-9550
Hickory, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Mahidol Univ-Ramathibodi Hosp, Fac Of Med, Bangkok, Thailand
Graduation Year: 1987

Data Provided by:
Piyapong Vongkovit, MD
(828) 324-9550
225 18th St SE
Hickory, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Mahidol Univ-Ramathibodi Hosp, Fac Of Med, Bangkok, Thailand
Graduation Year: 1987

Data Provided by:
John Oscar Del Charco, MD
(828) 326-3856
810 Fairgrove Church Rd
Hickory, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of South Fl Coll Of Med, Tampa Fl 33612
Graduation Year: 1993

Data Provided by:
Christopher R McDonald, MD
(828) 879-7536
PO Box 700
Valdese, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: La State Univ Sch Of Med In New Orleans, New Orleans La 70112
Graduation Year: 1972

Data Provided by:
Richard Orlowski, MD
(828) 324-9550
PO Box 3710
Hickory, NC
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Washington Univ Sch Of Med, St Louis Mo 63110
Graduation Year: 1978
Hospital
Hospital: Catawba Mem Hosp, Hickory, Nc; Frye Reg Med Ctr, Hickory, Nc
Group Practice: Northwestern Carolina Oncology & Hematology

Data Provided by:
Michael Noah Tate, MD
(828) 324-9550
PO Box 3710
Hickory, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1982
Hospital
Hospital: Catawba Mem Hosp, Hickory, Nc
Group Practice: Northwestern Carolina Oncology & Hematology

Data Provided by:
William Reginald Sigmon, MD
(828) 326-3856
810 Fairgrove Church Rd
Hickory, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1987

Data Provided by:
Shannon K Tomlinson, MD
810 Fairgrove Church Rd
Hickory, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Med Coll Of Ohio, Toledo Oh 43699
Graduation Year: 1998

Data Provided by:
Emmett Royce White, MD
PO Box 700
Valdese, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1954

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com